- Home
- JAZZ vs PAAS Comparison
JAZZ vs PAAS Comparison
Compare JAZZ & PAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- PAAS
- Stock Information
- Founded
- JAZZ 2003
- PAAS 1994
- Country
- JAZZ Ireland
- PAAS Canada
- Employees
- JAZZ N/A
- PAAS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- PAAS
- Sector
- JAZZ Health Care
- PAAS
- Exchange
- JAZZ Nasdaq
- PAAS Nasdaq
- Market Cap
- JAZZ 8.4B
- PAAS 9.4B
- IPO Year
- JAZZ 2007
- PAAS 1995
- Fundamental
- Price
- JAZZ $122.92
- PAAS $25.96
- Analyst Decision
- JAZZ Strong Buy
- PAAS Buy
- Analyst Count
- JAZZ 13
- PAAS 4
- Target Price
- JAZZ $187.15
- PAAS $28.63
- AVG Volume (30 Days)
- JAZZ 1.3M
- PAAS 3.4M
- Earning Date
- JAZZ 04-30-2025
- PAAS 05-07-2025
- Dividend Yield
- JAZZ N/A
- PAAS 1.54%
- EPS Growth
- JAZZ 41.75
- PAAS N/A
- EPS
- JAZZ 8.65
- PAAS 0.31
- Revenue
- JAZZ $4,068,950,000.00
- PAAS $2,818,900,000.00
- Revenue This Year
- JAZZ $7.30
- PAAS $4.15
- Revenue Next Year
- JAZZ $4.01
- PAAS $11.48
- P/E Ratio
- JAZZ $14.21
- PAAS $84.50
- Revenue Growth
- JAZZ 6.12
- PAAS 21.71
- 52 Week Low
- JAZZ $99.06
- PAAS $15.10
- 52 Week High
- JAZZ $148.06
- PAAS $27.47
- Technical
- Relative Strength Index (RSI)
- JAZZ 32.69
- PAAS 55.81
- Support Level
- JAZZ $137.74
- PAAS $25.63
- Resistance Level
- JAZZ $142.64
- PAAS $26.79
- Average True Range (ATR)
- JAZZ 3.87
- PAAS 0.88
- MACD
- JAZZ -2.12
- PAAS -0.02
- Stochastic Oscillator
- JAZZ 0.45
- PAAS 61.08
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.